Research Options:

Week of Expected Pricing 5/5/2023
Company Name ACELYRIN INC
Proposed Ticker SLRN
CUSIP 00445A100
Business Description A late-stage clinical biopharma company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. We are driven by our sense of urgency to bring life-changing therapies to patients globally, a core value that we refer to as courageous caring
Lead Underwriter Cowen and Company, LLC, Jefferies LLC, Morgan Stanley & Co. LLC, Piper Sandler & Co
Co-Managers N/A
Initial Shares 2,06,00,000
Revised Initial Shares 3,00,00,000
Initial Price $16.00-$18.00
Revised Price N/A
Final Price $18.00
Final Ticker SLRN

 

 

   
  © 2024 ICE Data Services. All rights reserved.